Pharmaceutical Grade 1197-18-8 Tranexamic Acid (OAP-066)

Tranexamic Acid

Product Name: Tranexamic Acid

Synonym: Tranexamic Acid; Trans-4-(Aminomethyl)cyclohexanecarboxylic acid; ;
Tranexamic Acid CAS No.: 1197-18-8
Tranexamic Acid Molecular formula: C8H15NO2
Tranexamic Acid Molecular weight: 157.21
Tranexamic Acid Packing: 25KG/Drum
Tranexamic Acid Content: 99%
Tranexamic Acid Appearance: White powder
Tranexamic Acid Grade: Pharmaceutical grade
Tranexamic Acid Category: Pharmaceutical raw material

Tranexamic Acid Product Application
Tranexamic acid for aminomethylbenzoic acid derivatives, is a kind of fibrinolytic hemostatic drug resistance, hemostatic mechanism with the same amino caproic acid, aminomethylbenzoic acid, but the effect is stronger, the intensity of 7 ~ 10 times that of amino caproic acid, aminomethylbenzoic acid 2 times, and similar toxicity. Tranexamic acid structure similar to the lysine, can be competitive inhibitory fibrinolytic enzyme on the fibrous protein adsorption, prevent its activation, protect the fibrin degradation by fibrinolytic enzyme and dissolved, ultimately achieve hemostatic effect. Limitations are suitable for the treatment of acute or chronic, or systemic primary fibrinolysis hyperfunction caused by all kinds of bleeding, such as the obstetric hemorrhage, renal hemorrhage, prostatic hypertrophy, hemorrhage, hemophilia, tuberculosis, coughing up blood, stomach bleeding, liver, lung, spleen and other visceral bleeding after the operation, etc; When the operation can also be used for abnormal bleeding and so on.

Tranexamic Acid Usage:
1. Hemostatic, significant effect on traumatic bleeding, preoperative prophylactic medication can decrease operation hemorrhage.
2. The chemical structure of tranexamic acid and lysine, competitive inhibition of plasminogen to fibrin adsorption, to prevent their activation, protect the fiber protein was not degraded by the enzyme and dissolved, ultimately achieve hemostasis effect.
3. All applicable in the treatment of acute or chronic, localized or systemic primary fibrinolysis hyperfunction caused by bleeding, such as obstetric hemorrhage, renal hemorrhage, hypertrophy of the prostate, hemophilia hemorrhage, pulmonary tuberculosis hemoptysis, bleeding in the stomach, liver, lung, spleen and other organs of hemorrhage after operation
4. The clinical effect of tranexamic acid on insect bites, eczema and dermatitis, simple purpura, chronic urticaria, artificial sex urticaria, rash and drug poisoning effect, also have certain effects on erythroderma, scleroderma, SLE, erythema multiforme, herpes zoster and alopecia areata, curative effect of hereditary angioedema is also good.

Tranexamic Acid CAS 1197-18-8 Tranexamic Acid
Tranexamic Acid CAS 1197-18-8 Tranexamic Acid
Tranexamic Acid CAS 1197-18-8 Tranexamic Acid
Tranexamic Acid CAS 1197-18-8 Tranexamic Acid
Tranexamic Acid CAS 1197-18-8 Tranexamic Acid